mTOR and cancer: many loops in one pathway

被引：343

作者：

Efeyan, Alejo ^{[1
,2
]}

Sabatini, David M. ^{[1
,2
,3
]}

机构：

[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA

[2] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA

[3] MIT, Koch Inst Integrat Res Canc, Cambridge, MA 02139 USA

来源：

CURRENT OPINION IN CELL BIOLOGY | 2010年 / 22卷 / 02期

关键词：

PROTEIN-KINASE; CELL-GROWTH; METABOLIC CHECKPOINT; MAMMALIAN TARGET; BINDING PARTNER; RAG GTPASES; COMPLEX; RAPAMYCIN; PHOSPHORYLATION; INHIBITION;

D O I：

10.1016/j.ceb.2009.10.007

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The mammalian target of rapamycin (mTOR) is a master regulator of cell growth and division that responds to a variety of stimuli, including nutrient, energy, and growth factors. In the last years, a significant number of pieces have been added to the puzzle of how mTOR coordinates and executes its functions. Extensive research on mTOR has also uncovered a complex network of regulatory loops that impact the therapeutic approaches aimed at targeting mTOR.

引用

页码：169 / 176

页数：8

共 58 条

[1] PI3K and mTOR inhibitors - a new generation of targeted anticancer agents [J].

Brachmann, Saskia ;

Fritsch, Christine ;

Maira, Saveur-Michel ;

Garcia-Echeverria, Carlos .

CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) :194-198

[2] p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling [J].

Budanov, Andrei V. ;

Karin, Michael .

CELL, 2008, 134 (03) :451-460

[3]

Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]

[4] Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation [J].

Choo, Andrew Y. ;

Yoon, Sang-Oh ;

Kim, Sang Gyun ;

Roux, Philippe P. ;

Blenis, John .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (45) :17414-17419

[5] The tuberous sclerosis complex [J].

Crino, Peter B. ;

Nathanson, Katherine L. ;

Henske, Elizabeth Petri .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (13) :1345-1356

[6] Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 [J].

Dibble, Christian C. ;

Asara, John M. ;

Manning, Brendan D. .

MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (21) :5657-5670

[7] Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers [J].

Engelman, Jeffrey A. ;

Chen, Liang ;

Tan, Xiaohong ;

Crosby, Katherine ;

Guimaraes, Alexander R. ;

Upadhyay, Rabi ;

Maira, Michel ;

McNamara, Kate ;

Perera, Samanthi A. ;

Song, Youngchul ;

Chirieac, Lucian R. ;

Kaur, Ramneet ;

Lightbown, Angela ;

Simendinger, Jessica ;

Li, Timothy ;

Padera, Robert F. ;

Garcia-Echeverria, Carlos ;

Weissleder, Ralph ;

Mahmood, Umar ;

Cantley, Lewis C. ;

Wong, Kwok-Kin .

NATURE MEDICINE, 2008, 14 (12) :1351-1356

[8] Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 [J].

Feldman, Morris E. ;

Apsel, Beth ;

Uotila, Aino ;

Loewith, Robbie ;

Knight, Zachary A. ;

Ruggero, Davide ;

Shokat, Kevan M. .

PLOS BIOLOGY, 2009, 7 (02) :371-383

[9] The regulation of AMPK β1, TSC2, and PTEN expression by p53:: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways [J].

Feng, Zhaohui ;

Hu, Wenwei ;

de Stanchina, Elisa ;

Teresky, Angelika K. ;

Jin, Shengkan ;

Lowe, Scott ;

Levine, Arnold J. .

CANCER RESEARCH, 2007, 67 (07) :3043-3053

[10] PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms [J].

Freeman, DJ ;

Li, AG ;

Wei, G ;

Li, HH ;

Kertesz, N ;

Lesche, R ;

Whale, AD ;

Martinez-Diaz, H ;

Rozengurt, N ;

Cardiff, RD ;

Liu, X ;

Wu, H .

CANCER CELL, 2003, 3 (02) :117-130

← 1 2 3 4 5 6 →